GAO Says FDA Slow To Debar Convicted Investigators

Law360, New York (October 23, 2009, 6:46 PM EDT) -- The U.S. Food and Drug Administration lags in debarring clinical investigators who have been convicted of crimes from continuing to conduct research or overseeing patient safety in medical trials, according to a government watchdog report.

The U.S. Government and Accountability Office said Thursday the FDA needed to speed up the time it takes to determine whether medical professionals should be debarred from conducting investigations. And the agency should expand its authority and the scope of its investigator disqualification program, the report said.

“The FDA had failed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.